Talk # Abstract # Title/Author

1

11389

Patient Reported Outcomes After Sacral Resection Based On The Nerve Roots Sacrificed
Olivier Van Wulfften Palthe, MD

2

11231

Validation Of Eq-5D In Patients Treated For Extremity Sarcoma
Robert John Grimer, FRCS

3

11473

The Validity, Reliability, And Responsiveness Of Commonly Used Orthopedic Outcome Measures, Cancer Specific Measures, And Patient Reported Functional And Quality Of Life Measures
Justin E Bird, MD

4

11404

Patient Reported Outcomes And Clinician Reported Outcomes Commonly Used In Orthopedics And Oncology
Justin E Bird, MD

5

11005

Are Sports Activity Levels Reached In Long-Term Survivors Of Bone And Soft-Tissue Sarcomas After Limb Salvage Surgery Associated With Better Quality Of Life?
Gerhard Martin Hobusch, MD

6

10925

The Impact Of A Communal Multidiscipinary Team On Limb Salvage In Lagos, Nigeria
Oluwaseyi Kayode Idowu

7

10809

Service Redesign For Tertiary Sarcoma Referral Service
Hazem Wafa, MD

8

10759

Commercial Activity Monitor For Assessing Free-Living Limb Salvage Outcome In Pediatric Lower Extremity Bone Cancer
Ernest U Conrad III, MD

9

11197

Visual Analytics For The Integration Of Health Related Quality Of Life Data Into “Point Of Contact” Clinical Care In Orthopaedic Oncology: A Pilot Study
Justin E Bird, MD

10

10710

The Variability In Surgical Margin Reporting In Limb Salvage Surgery For Sarcoma
Benjamin J Miller, MD, MS

11

10882

Long Term Outcomes And Satisfaction Of Rotationplasty Patients In The Treatment Of Lower Extremity Sarcomas
Courtney M Grimsrud, MD

12

10896

The Rate And Causes Of 90-Day Unplanned Re-Admission After Soft-Tissue Sarcoma Resection.
Robert J. Wilson, MD

13

10754

Augmented-Reality Assistance In Bone Tumor Surgery
Hwan Seong Cho

14

11365

Enhancing Precision And Accuracy In Bone Tumour Treatment; An Experimental Comparison Of Freehand, Computer Assistance (Cas) And A Novel Universal Cas Saw Guide.
Jasper G. Gerbers, MD

15

11190

3D Surgical Planning And Patient Specific Instruments (Psis) Can Achieve Good Accuracy For Complex Bone Resections In Bone Sarcoma Patients.
Kwok Chuen Wong, FRCS (ORTHO)

16

11161

Standardizing Bony Sarcoma Margin Documentation With Intraoperative Computer-Aided Navigation
Ernest U Conrad III, MD

17

10584

What Is The Expected Learning Curve In Computer Assisted Navigation For Bone Tumor Resection?
Jose Ignacio Albergo, MD

18

10642

Computer Navigation Aided Precision Resection Of Sacral Chordomas
Yongkun Yang

19

10766

Can You Improve Outcomes Of P1+S Resections Using Navigation?
Lee Jeys, FRCS

20

11257

Patient-Specific 3D-Printed Registration And Cutting Guides For Hemicortical Resection And Reconstruction Of Metaphyseal Tumors Around The Knee
Florencio Segura

21

11105

Mcs110, An Anti-Csf-1 Antibody, For The Treatment Of Pigmented Villonodular Synovitis
Edward Y Cheng, MD

22

11327

Long-Term Treatment Of Tenosynovial Giant Cell Tumor (Tgct) With Plx3397, A Selective Colony Stimulating Factor 1 Receptor (Csf1r) Kinase Inhibitor
John H Healey, MD, FACS

23

11279

Real-Time Tissue Discrimination During Soft Tissue Sarcoma Surgical Resection With Raman Spectroscopy
Zain Sherali Gowani

24

11123

Pet Response Criteria (Percist) Predict Progression-Free Survival And Time To Local Or Distant Progression After Chemotherapy With Regional Hyperthermia For Soft-Tissue Sarcoma
Hans Roland Dürr

25

10624

Prophylactic Antibiotic Regimens In Tumor Surgery (Parity): A Pilot Multi-Center Randomized Controlled Trial
Michelle Ghert, MD

26

10003

Prospective Outcome Study Of Proton Therapy For Chordomas And Chondrosarcomas Of The Spine
Daniel Indelicato, MD

27

10928

Today's Challenges In 3D Printing Process Chain Of Custom-Made Implants
Peter Scheinemann

28

10757

Implantation Of Customized 3-D Printed Titanium Prosthesis In Limb Salvage Surgery: A Case Series And Review Of The Literature
Zheng Guo

29

10615

Raman Spectroscopy Demonstrates Pth Prevention Of Radiation-Induced Damage On Bone Mineral Properties And Blunting Of Bone Matrix Damage In An Irradiated Mouse Model
Timothy A. Damron, MD

30

10818

Radiofrequency Ablation Of Atypical Cartilaginous Tumors In The Long Bones; Proof Of Principle In 44 Patients
Dr PC Jutte

31

11335

Identification Of Cd146 As A Marker Of Tumor-Propagating Cells In Human Sarcomas Leads To Novel Treatment Opportunities
Jay S Wunder, MD

32

10795

Three-Dimensional (3D) Culture Of Bone Derived 786-O Renal Cell Carcinoma Retains Relevant Clinical Characteristics Of Bone Metastases
Robert L Satcher Jr, MD

33

11494

Inhibition Of Plk Induces Growth Arrest And Apoptosis In Tumorigenic Os Cells
Maria V. Guijarro, PHD

34

11418

Drivers Of Mesenchymal-Epithelial Transitions In Sarcomas
Suzanne Bartholf Dewitt, DVM

35

10763

Clinical Outcomes Of Patients Reconstructed With Heat-Treated Autograft After Resection Of Malignant Musculoskeletal Tumors
Kunihiro Ikuta, MD

36

11442

Extra-Corporeal Irradiated Bone Autografts In Reconstruction Of Diaphyseal Tibial Defects
Mobolaji Ajekigbe, BS

37

11175

Recycled Autograft Augmented With Vascularized Fibular Graft For Reconstruction Of Bone Defects After Tumor Resection
Kyung Il Kim

38

11170

Complications Of Recycled Autograft For Reconstruction After Malignant Musculoskeletal Tumor Resection
Min Wook Joo, MD

39

11379

Biological Reconstruction After Resection Of Malignant Bone Tumors
Rainer Baumgart, MD

40

11399

Primary Arthroplasty In Healed Osteoarticular Allografts In Patients With History Of Primary Femoral Bone Tumors
Bianca Monica Verbeek, MD

41

10814

Bone-Tendon-Bone Allograft Reconstruction For Peri-Patella Sarcoma Cases
Jungo Imanishi

42

10693

Functional Neuro-Vascularized Muscle Transfer For Oncological Reconstruction Of Extremity Sarcoma
Keiichi Muramatu

43

11206

Is It The Expandable Prosthesis The Only Reconstructive Option After Distal Femur Resections In Children With High-Grade Bone Sarcomas?
Laura Campanacci, MD

44

11384

Lower Limb Recostructions With Bone Massive Allograft In Pediatric Patients
Giovanni Beltrami, MD

45

11422

Functional Outcome In Children Undergoing Resection-Arthrodesis For Malignant Tumors Around The Knee Joint
Shah Alam Khan, MS, DNB, MRCSEd, FRCS, M.Ch.Orth

46

11162

Femoral Physeal Fixation And Growth Abnormalities After Pediatric Limb Salvage
Ernest U Conrad III, MD

47

11282

A Novel “Homolateral Femur Rotation-Lengthening With Allograft Transplantation Technique” As An Option Of Reconstruction For Huge Defects After Pelvic Tumor Resection: Technical Note And Early Experience
Xiaohui Niu, MD

48

11359

Allograft Reconstruction For The Proximal Humerus - Does It Work?
Daniel Andreas Müller, MD

49

10598

Outcome And Complications Following Free Fibula Reconstruction For Oncologic Defects Of The Extremities
Matthew Thomas Houdek, MD

50

10730

Massive Pelvic Allograft Reconstruction Of The Acetabular Area: Management Of Hip Mechanical Failure
Davide Donati, MD

51

11443

Revision Surgery Does Not Lead To Increased Rate Of Failure In Proximal Humerus Reconstruction With A Metallic Endoprosthesis: A Multi-Center Study
John Groundland, MD

52

11272

The Use Of Reverse Total Shoulder Arthroplasty In Primary And Revision Implants After Resection Of Tumors Of The Proximal Humerus: A Report Of 20 Cases
Professor Pietro Ruggieri

53

10681

Internal Hemipelvectomy Reconstruction With Ice-Cream Cone Type Prosthesis
Irene Barrientos-Ruiz, MD

54

11142

Managing Large Bone Defects With Custom Spacers In Patients With Musculoskeletal Infections
Joseph Benevenia, MD

55

10845

Gait Analysis In Patients With Endoprosthesis Replacement Around The Knee
Prof. Dr. Vivek Ajit Singh, MBBS, MD

56

11444

Extra-Articular Resection Of The Knee For Distal Femur Bone Sarcomas: A Retrospective Review Of 30 Cases
Eleonora Marini, MD

57

11355

Uni- Or Bipolar Proximal Femoral Endoprostheses Following Tumour Reconstruction: Are Acetabular Resurfacings Necessary?
Jonathan Daniel Stevenson

58

10563

Endoprosthetic Replacement For Malignant Tumors Of The Proximal Femur: A Consecutive Series Of 211 Patients
Matthew Thomas Houdek, MD

59

11397

Two-Institution Experience Of A Non-Invasive Expandable Endoprosthesis In The Pediatric Population
Odion Binitie, MD

60

11140

Intercalary Endoprosthetic Reconstruction For Skeletal Defects Of The Femur, Tibia, And Humerus
Joseph Benevenia, MD

61

11460

The Lumic Prosthesis For Pelvic Reconstruction After Periacetabular Tumor Resection: Clinical Results From A European Collaborative Study
Sander Dijkstra, MD

62

11055

X-Ray Predictors Of Osseointegration For Uncemented Oncologic Implants
Ernest U Conrad III, MD

63

11406

Very Long Term Outcomes Following Endoprosthetic Replacements
Robert John Grimer

64

11278

Long Term Results Of Cemented, Hydroxyapatite Coated Distal Femoral Replacements. Has Aseptic Loosening Been Abolished And If So, Why Do They Fail?
Robert John Grimer

65

11324

Silver Coated Endoprosthesis: Short To Medium Term Follow-Up At The Royal Orthopaedic Hospital
Jose Ignacio Albergo, MD

66

11320

Implant Survivorship And Modes Of Failure For Proximal Femoral, Distal Femoral And Tibial Reconstruction With Compressive Endoprosthetic Osseointegration Fixation
Ryland Kagan, MD

67

11318

Proximal Femoral And Proximal Tibial Compressive Osseointegration: Intermediate Term Outcomes
Hwan-Seong Cho, MD

68

11295

Reconstruction After Tumor Resection Of The Elbow - What Works Best?
Giovanni Beltrami, MD

69

11246

Endoprosthetic Failure After Resection Of Primary Or Secondary Bone Tumors In The Proximal Humerus And Reconstruction With The Mutars™ System – A Systematic Analysis
Arne Streitbürger

70

11294

Denosumab As Adjuvant Treatment For Giant Cell Tumor Of Bone - Risks And Benefits For The Oncologic Surgeon
Giovanni Beltrami, MD

71

11205

Is Denosumab Boon Or Bane In Complicated Giant Cell Tumour Treatment? - Single Institution Experience - 72 Cases
Pramod Chinder

72

11476

The Use Of Denosumab In Giant Cell Tumour (Gct) Of Bone: A Review Of 44 Patients
Czar Louie Gaston, MD

73

10006

Denosumab – A New Bullet In The Armamentarium For Giant Cell Tumor
Ajay Puri, MD

74

10676

Retrospective Evaluation Of Cartilage Tumors Of Long Bones Under Clinico-Radiological Surveillance
Venkatesan Sampath Kumar

75

10103

Osteoarthritis of the Hip in Fibrous Dysplasia of the Proximal Femur
Ilkyu Han

76

11244

Coralline Hydroxyapatite Reduces Local Recurrence Of Benign Bone Lesions
Melissa Nicole Zimel, MD

77

11480

Risk Factors In Allogenous Strut Graft Surgery In Fibrous Dysplasia Of The Proximal Femur.
Sander Dijkstra, MD

78

10912

Freezing Nitrogen Ethanol Composite (Fnec), A New Effective Cryoablation Technology As An Adjuvant Modality Treatment For Giant Cell Tumor Of Bone
Po-Kuei Wu

79

11464

Role Of Bisphosphonates In Giant Cell Tumor Of Bone- A Prospective Randomized Control Study.
Shisir Rastogi

80

10568

Distal Radius Giant Cell Tumor Resection And Reconstruction With Non-Vascularized Iliac Crest Graft Wrist Arthrodesis
Tao Wang, MD

81

11434

Treatment Of Aneurysmatic Bone Cysts
Johan Pot

82

11346

Complications And Outcome After Surgical Treatment Of Pelvic Sarcomas – Does Competing Risk Add To Treatment Considerations?
Reinhard Windhager, MD

83

11313

Morbidity, Mortality And Blood Loss Associated With Pelvic And Sacral Tumour Surgery
Michael Parry, FRCS (ORTHO), MD

84

11146

Resection Of The Acetabulum And Pelvis: Should We Still Offer Reconstructive Options?
Joseph Benevenia, MD

85

11421

Functional Outcome Following “No Reconstruction” In Patients Undergoing Periacetabular (Type-Ii) Pelvic Resection
Shah Alam Khan, MS, DNB, MRCSEd, FRCS, M.Ch.Orth

86

11160

Male And Female Sexual Dysfunction Following Pelvic Tumor Surgery--Sexual Dysfunction Following Pelvis Surgery
Ernest U Conrad III, MD

87

11474

Intrapelvic And Lumbopelvic Reconstruction Outcomes After Acetabulum-Sparing Tumor Resections
Harzem Ozger

88

11157

Functional Outcome Following Total Sacrectomies Without Spino-Pelvic Reconstruction
Piya Kiatisevi

89

10129

Sacral Chordoma: A Clinical Review Of 157 Cases With 30-Year Experience In A Single Institute
Xin Sun

90

10716

Conditional Survival And Functional Outcome Following Surgical Treatment For Sacral Chordoma: A Monocentric Retrospective Review Of 115 Consecutive Cases
Tao Ji, MD

91

11152

Surgical Strategies In Patients With Spinal Giant Cell Tumor: Twelve-Year’S Clinical Experience And Outcomes
Xin Sun

92

11380

Limb Lengthening After Internal Hemipelvectomy With The Fitbone-System
Rainer Baumgart, MD

93

11150

Intra-Aortic Balloon Occlusion To Prevent Bleeding In Pelvic Tumours: A Case Control Study
Michele Boffano, MD

94

11176

Giant Cell Tumor Of The Sacrum Treated With Conservative Surgery: 35 Years’ Experience
Chandhanarat Chandhanayingyong, MD

95

10059

Microwave Ablation Of Pelvic Malignant Bone Tumors
Qingyu Fan

96

11266

The Effect Of Surgical Margins On Local Recurrence And Survival After Resection Of High-Grade Soft Tissue Sarcomas Of The Extremities: Through The Eyes Of A Multi-State Model.
Michiel Van De Sande, MD, PHD

97

11323

Clinical Outcomes Of Unplanned Soft Tissue Sarcoma Excision In Comparison With Primary Planned Excision At Sarcoma Center; The Impact Of Residual Tumor In Re-Excision Specimen
Jungo Imanishi

98

11305

Locally Recurrent Soft Tissue Sarcoma: Outcomes With Re-Irradiation And/Or Surgical Excision
Anthony M. Griffin, MSc

99

11310

What Is The Significance Of A Fungating Soft Tissue Sarcoma?
Michael Parry, FRCS (ORTHO), MD

100

11121

Fdg Pet-Ct Response After Neoadjuvant Chemotherapy Continues To Predict Progression Free Survival At Mid-Term In Prospective Trial For Soft Tissue Sarcomas
Edward Y Cheng, MD

101

11376

Brachy Vac Treatment Of Superficial Malignancies- Results Of A Consecutive Case Series
Richard Louis McGough, MD

102

11255

Retrospective Review Of The Adequacy Of Community Magnetic Resonance Imaging (Mri) For Soft Tissue Sarcoma In The Periphery
David Joyce, MD

103

11236

Vancomycin Powder Reduces Risk Of Wound Complication In Orthopaedic Tumor Surgery
Christina J Gutowski, MD

104

11293

Myxofibrosarcoma: A Difficult-To Treat Soft Tissue Sarcoma - Considerations After 85 Patients
Giovanni Beltrami, MD

105

11250

Intraoperative Differentiation During Soft Tissue Sarcoma Excision Using Near Infrared Autofluorescence Spectroscopy
John Q Nguyen

106

11445

The Influence Of Diabetes, Obesity & Anatomic Location On The Development Of Post-Operative Wound Infections Following Soft Tissue Sarcoma Resection: A Multi-Institutional Study
Jeremy White, MD

107

11283

Does The Use Of Wound Vacuum Assisted Closure (Vac) Therapy Increase The Risk Of Local Recurrence After Sarcoma Excision?
Phillip A Taylor, MD

108

10694

Treatment Of Sarcoma Lung Metastases With External Beam Radiotherapy: Experience At A Tertiary Referral Center
Adam Lindsay, MD

109

10769

A Novel System For The Surgical Staging Of Primary High-Grade Osteosarcoma: The Birmingham Classification
Lee Jeys, FRCS

110

10873

Development And Validation Of A Pretreatment Prognostic Index To Predict Death And Lung Metastases For Extremity Osteosarcoma
Jian Tu

111

11183

Post-Metastasis Survival In High-Grade Extremity Osteosarcoma: A Retrospective Analysis Of Prognostic Factors Of 126 Patients.
Wanlim Kim

112

11270

The Role Of 18F-Fdg Pet/Ct For The Detection Of Recurrent Osteosarcoma
Pietro Ruggieri, MD

113

11363

Why Can’T We All Speak The Same Language? An Analysis Of The Definition And Significance Of Margins In The Euramos-1 Trial
Robert John Grimer

114

11262

The Effect Of Surgical Timing On The Outcome Of Localized Extremity Osteosarcoma
Soo-Yong Lee

115

11439

Osteofibrous-Dysplasia-Like-Adamantinoma And Adamantinoma: A Clinical, Radiological And Histological Analysis Of 82 Cases
Emile M Schutgens, MD

116

11259

Prognostic Factors And Outcomes Of Dedifferentiated Chondrosarcoma – A Single Institution Experience
Christopher John Matthews, MD

117

11495

Is Radiation Worth The Risk For Diffuse Large B-Cell Lymphoma Of Bone In The Era Of Chop-R Therapy?
Nicholas Bernthal, MD

118

10610

Is Needle Biopsy Clinically Useful In Pre-Operative Grading Of Central Chondrosarcoma Of Pelvis And Long Bones?
Pablo Roitman, MD

119

10874

Is Pet-Ct An Accurate Method For The Differential Diagnosis Between Chondroma And Chondrosarcoma?
Reynaldo Jesus-Garcia, MD

120

10010

Tumor Necrosis: Does It Define The Need For Post Operative Radiotherapy In Ewing's Sarcoma?
Ajay Puri, MD

121/p>

10655

Periosteal Osteosarcoma; The University Of Florida Experience
Chung Chan, MBBS

122

10665

Adamantinoma Of The Long Bones_ A Retrospective Study Of 18 Cases
Zhiping Deng, MD

123

10991

Survival In Mesenchymal Chondrosarcoma: 205 Cases From The Seer Database
Lukas Nystrom, MD

124

11423

Do We Need To Remove The Biopsy Tract In Patients Undergoing Surgery Following Neo- Adjuvant Chemotherapy For Primary Bone Tumors?
Shah Alam Khan, MS, DNB, MRCSEd, FRCS, M.Ch.Orth

125

10872

Patterns Of Local Recurrence And Metastatic Progression Following Treatment Of Bone Sarcomas
Cara Cipriano

126

11448

Ct Data Evaluation Of Proximal Femur Malignant Tumors
Oleg Vyrva, MD

127

11463

Surgical Treatment Of Conventional Primary Central Chondrosarcoma Of Pelvic Bone: A Multicenter Study In 164 Patients
Sander Dijkstra, MD

128

11144

Ewing Sarcoma: Only Patients With 100% Of Necrosis After Adjuvant Chemotherapy Should Be Classified As Good Responders.
Jose Ignacio Albergo, MD

129

11398

Distinct And Overlapping Genetic Changes In Ostesarcoma Across Species
William Eward, MD, DVM

130

11431

Intra-Tumoral Heterogeneity In Osteosarcoma And Its Therapeutic Impolications
Padraic P. Levings, PHD, BS

131

11336

Microscopic Tumor Emboli As One Of Important Prognostic Factors In Stage-Ii Osteosarcoma
Science Metadilogkul

132

11243

Three-Dimensional Drug-Screening Platform For Progression Of Osteosarcoma Micrometastases Demonstrates Heterogeneous Response To Map Chemotherapy
Christopher Collier, MD

133

11417

Opportunities For Drug Repurposing In Osteosarcoma: A Screen Of Fda-Approved Oncology Drugs In A Micrometastatic Model Of Disease
Christopher Collier, MD

134

10724

Hypomethylation Of Irx1 A Poor Marker In Circulating Tumor Dna And Drives Osteosarcoma Metastasis Via Cxcl14/Nf-Kb Upregulation
Jin Wang

135

11477

Epigenetic Reprogramming Of Osteosarcoma Tumor Initiating Cells Alters Histologic And Metastatic Phenotype
Emma Maria Viktoria Hyddmark, BS

136

11199

A Health Services Comparison Of Surgery Followed By Radiation Therapy Versus Radiation Therapy Alone For Patients With Metastatic Epidural Spinal Cord Compression
Justin E Bird, MD

137

11339

Surgical Failure And Disease Progression In A New Era Of Metastatic Skeletal Disease
Elizabeth Scott

138

11352

Prognostic Factors In Breast Carcinoma Patients With Metastatic Disease In The Peripheral Skeleton
Jonathan Daniel Stevenson

139

11403

Prognostication Of Survival In Patients Who Underwent Operative Treatment Of Metastatic Spine Disease
Nuno Rui Cools Paulino Pereira, MD, MSC

140

10830

Prophylactic Fixation Of Impending Pathologic Fractures: In-Hospital Cost And Complication Analysis As Compared To Acute Fracture Fixation
Nicole Kellan Behnke, MD

141

11314

Assessing Physical Function In Patients With Lower Extremity Bone Metastases
Stein Jasper Janssen, MD

142

10683

Thromboembolic Disease In Metastatic Femoral Lesions: A Comparison Between Prophylactic Fixation Versus Fixation After Pathological Fracture
Arun Aneja

143

11349

A Simple Model To Predict Survival In Patients With Metastases Of The Long Bones: The Bollen Model
Sander Dijkstra, MD